Who Is a Good Candidate for Wegovy® or Zepbound®?
Wegovy®. Zepbound®. Which one is best for you?
Both medications have genuinely changed the conversation around weight loss, but they are not designed for everyone. Eligibility comes down to more than just wanting to lose weight. Your BMI, your health history, any conditions you are managing, and what a provider determines is medically appropriate for your situation all factor in.
In this guide, we’ll walk through what providers look for, what makes someone a good fit for one medication over the other, and what the evaluation process actually looks like.
What Are Wegovy® and Zepbound® Designed to Do?
Both are weekly injectable medications approved by the FDA to support weight management in adults, but they work through slightly different mechanisms. Knowing the basics helps you understand why candidacy requirements exist in the first place.
How Wegovy® Works
Wegovy® contains semaglutide, which mimics a hormone your body naturally produces after eating called GLP-1. That hormone signals your brain to reduce appetite, slows how quickly your stomach empties, and helps stabilize blood sugar. The result is that you feel full sooner and stay satisfied longer between meals.
How Zepbound® Works
Zepbound® contains tirzepatide, which activates two hormonal pathways rather than one. It targets both GLP-1 and GIP receptors, the second being another hormone involved in how your body processes and stores fat. The dual-pathway approach generally produces a stronger appetite-suppressing and metabolic effect, which shows up in clinical studies as higher average weight loss.
Wegovy® vs. Zepbound®: Quick Comparison
Before diving into eligibility specifics, here is a side-by-side overview of where the two medications align and where they differ.
| Feature | Wegovy® | Zepbound® |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| How it works | GLP-1 receptor agonist | Dual GLP-1 and GIP receptor agonist |
| FDA-approved age | Adults and adolescents 12+ | Adults only |
| BMI requirement | 30+, or 27+ with a health condition | 30+, or 27+ with a health condition |
| Additional approvals | Cardiovascular risk reduction | Obstructive sleep apnea |
| Dosing | Weekly injection | Weekly injection |
| Average weight loss (studies) | 10–15% of body weight | ~20%+ of body weight |
Both medications share the same BMI thresholds and are used under medical supervision. The differences come into play based on your age, specific health conditions, and what your provider determines is the better clinical fit for your situation.
BMI Requirements for Wegovy® or Zepbound®
BMI, or body mass index, is the primary threshold providers use to assess whether you may qualify. Both medications share the same criteria.
You may be eligible if you have:
A BMI of 30 or higher, which is classified as obesity
A BMI of 27 or higher alongside at least one weight-related health condition
BMI is a starting point, not the whole picture. Providers always consider it alongside your full medical history and health goals rather than treating it as a standalone qualifier.
Weight-Related Health Conditions That Support Eligibility
If your BMI is 27 or higher but falls below 30, you may still qualify if you are managing at least one weight-related health condition. These conditions matter because excess weight directly worsens them, and weight loss has been shown to meaningfully improve outcomes for all of them.
Qualifying conditions typically include:
High blood pressure
Type 2 diabetes or prediabetes
High cholesterol or other abnormal lipid levels
Obstructive sleep apnea, a condition where breathing repeatedly stops during sleep
Providers look at your overall health risk. If your weight is contributing to or worsening a condition you are already managing, that context carries significant weight in the eligibility assessment.
Does Age Affect Eligibility?
Age requirements differ between the two medications based on their FDA approvals, and this is one area where Wegovy® and Zepbound® are not interchangeable.
Who Can Use Wegovy®?
Wegovy® is approved for adults and for adolescents aged 12 and older with obesity. It is the only one of the two with a pediatric indication, making it the option available for younger patients between the two.
Who Can Use Zepbound®?
Zepbound® is currently approved for adults only. Its clinical trials were conducted in adult populations, and the FDA approval reflects that scope.
Situations Where One Medication May Be Preferred
Beyond age, specific FDA-approved indications distinguish the two medications and may influence what your provider recommends.
When Wegovy® May Be Recommended
Wegovy® has received FDA approval not only for weight management but also for reducing the risk of serious cardiovascular events, including heart attack and stroke, in adults who are overweight or obese and already have established cardiovascular disease. For patients in that situation, it carries an additional evidence-backed benefit beyond weight loss alone.
When Zepbound® May Be Recommended
Zepbound® holds FDA approval for weight management and has also received approval for treating moderate to severe obstructive sleep apnea in adults with obesity. For patients dealing with sleep apnea alongside their weight concerns, that dual indication makes it a particularly relevant option to explore.
Neither medication is the universal better choice. The right recommendation comes from your full clinical picture.
Who Should Not Take Wegovy® or Zepbound®?
Both medications have specific contraindications, meaning situations where they are not considered safe or appropriate. Your provider will screen for these during your evaluation.
Certain Thyroid Conditions
Both medications carry a warning related to a type of thyroid cancer called medullary thyroid carcinoma, or MTC. If you have a personal or family history of MTC, or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), these medications are not recommended. This is a firm contraindication.
Digestive Conditions
People with gastroparesis, a condition where the stomach empties too slowly, or other serious gastrointestinal conditions may not be suitable candidates. Because both medications slow gastric emptying as part of how they work, these conditions can be significantly worsened by treatment.
Pancreatitis History
A history of pancreatitis, which is inflammation of the pancreas, requires careful provider evaluation. It does not automatically disqualify you, but it is a factor your provider will weigh before recommending either medication.
Pregnancy and Family Planning
Both medications are not recommended during pregnancy, breastfeeding, or in the period leading up to a planned pregnancy. Providers typically recommend stopping treatment at least two months before attempting conception. Family planning conversations are a standard part of the candidacy evaluation for anyone who may become pregnant.
What Happens During a Weight-Loss Consultation?
A weight-loss consultation is a full medical evaluation, not just a prescription appointment. Your provider reviews your complete picture before making any recommendations.
You can expect the conversation to cover:
Your medical history, including past weight-loss attempts and what worked or did not
Your current medications, since some interact with or influence the choice between the two
Your existing health conditions and how well they are currently managed
Your lifestyle, including eating habits, activity level, sleep, and stress
Your goals and what a realistic timeline looks like for your situation
At Blue Sky Laser & Tox, medical weight loss is built around this kind of comprehensive evaluation, with ongoing provider support throughout treatment rather than a one-time prescription.
How to Know if Wegovy® or Zepbound® Is the Right Next Step
Sitting with a few honest questions before your consultation helps you get more out of the conversation:
Have you made consistent efforts to lose weight through nutrition and exercise without lasting results?
Does your current BMI meet the thresholds above?
Are you managing any weight-related health conditions affecting your quality of life?
Are you prepared for the long-term commitment that comes with medically supervised weight loss?
Are there any medical history factors, like thyroid conditions or pancreatitis, worth flagging?
None of these determines your eligibility on its own, and self-assessment is not a substitute for a clinical evaluation. They are simply a way to arrive at your consultation prepared and clear on what you want to accomplish.
Ready to Find Out if You Qualify for Wegovy® or Zepbound®?
Determining who is a good candidate for Wegovy® or Zepbound® involves more than checking a BMI number. Your full health picture, including medical history, weight-related conditions, age, and treatment goals, all factor into what a provider recommends.
Both medications have specific approved indications and contraindications that make a professional evaluation the only reliable way to determine whether they are appropriate for you.
Schedule a consultation with Blue Sky Laser & Tox or call (703) 966-3223 to discuss your eligibility, review your health history, and build a personalized medical weight-loss plan designed around your goals.